US equities |
NVDA $239.62 ▲+2.43% SPCX $169.25 ▲+6.47% MU $1,062.89 ▼-1.12% TSLA $379.80 ▲+2.49% SNDK $1,702.59 ▼-1.01% MSFT $527.92 ▲+2.01% INTC $116.06 ▼-2.74% META $742.65 ▲+2.00%
FinancialContent

Cara Therapeutics, Inc. - Common Stock (NQ:CARA)

5.320 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
Dow Tumbles 250 Points Following Powell's Comments; Crude Oil Down 2% ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday. The Dow traded down 0.77% to 33,172.39 while the NASDAQ fell 0.72% to 11,591.36. The S&P 500... 
Via Benzinga
News headline image
US Stocks Mixed Ahead Of Powell Testimony; Dick's Sporting Goods Posts Upbeat Earnings ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 20 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.03% to 33,420.92 while the NASDAQ rose... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Earnings Outlook For Cara Therapeutics ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For February 17, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For February 6, 2023 ↗
 
Via Benzinga
News headline image
DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
Wells Fargo cut the price target for Cheniere Energy, Inc. (NYSE: LNG) from $236 to $230. Wells Fargo analyst Michael Blum maintained an Overweight rating. Cheniere Energy shares fell 4.8% to close at... 
Via Benzinga
News headline image
Cara Therapeutics Gets Price Targets Cuts By Analysts After Weak Q4 Results ↗
Cara Therapeutics, Inc. (NASDAQ: CARA) posted downbeat Q4 results. Cara Therapeutics posted a Q4 loss of $0.56 per share, versus market expectations of $0.32 per share. The company’s quarterly sales... 
Via Benzinga
News headline image
Nutanix, Cara Therapeutics, Tremor International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
These 2 Stocks Are Plunging After Hours Monday ↗
The market closed mixed, but these two companies gave investors some bad news. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
From Cara Therapeutics, Inc.
Via GlobeNewswire
News headline image
Cannabis Stock Movers For March 3, 2023 ↗
 
Via Benzinga
News headline image
Bearish Sentiment Across The Cannabis Space - Check Full Movers For February 21, 2023 ↗
 
Via Benzinga
News headline image
Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
From Cara Therapeutics, Inc.
Via GlobeNewswire
News headline image
Bullish Sentiment Across The Cannabis Space - Check Full Movers For February 20, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For February 15, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From February 14, 2023 ↗
 
Via Benzinga
News headline image
Bullish Friday For Marijuana Stocks - iAnthus Capital Hldgs, Green Thumb Industries Among Top Gainers ↗
 
Via Benzinga
News headline image
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatment 
From Cara Therapeutics, Inc.
Via GlobeNewswire
News headline image
Bullish Tuesday For Marijuana Stocks - iAnthus Capital Hldgs, TerrAscend Among Top Gainers ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For January 30, 2023 ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From January 25, 2023 ↗
 
Via Benzinga
News headline image
Marijuana Stock Movers For January 20, 2023 ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From January 19, 2023 ↗
 
Via Benzinga
News headline image
Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Gainers And Losers From January 12, 2023 ↗
 
Via Benzinga
Marijuana Stock Movers For January 9, 2023 ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From January 5, 2023 ↗
 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >